Cleared Traditional

K031622 - WALLACE DUAL LUMEN OOCYTE RETRIEVAL SETS

K031622 is an FDA 510(k) clearance for WALLACE DUAL LUMEN OOCYTE RETRIEVAL SETS, manufactured by Portex , Ltd.. The device is a Class 2 Obstetrics & Gynecology device with product code MQE cleared through the Traditional 510(k) pathway after a 34-day FDA review.

K031622 · Portex , Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2003
Decision
34d
Days
Class 2
Risk

K031622 is an FDA 510(k) clearance for the WALLACE DUAL LUMEN OOCYTE RETRIEVAL SETS. Classified as Needle, Assisted Reproduction (product code MQE), Class II - Special Controls.

Submitted by Portex , Ltd. (England Ct21 6db, GB). The FDA issued a Cleared decision on June 26, 2003 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6100 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K031622

510(k) Number K031622 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2003
Decision Date June 26, 2003
Days to Decision 34 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
127d faster than avg
Panel avg: 161d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQE Device Classification - Class 2, Special Controls

Product Code MQE Needle, Assisted Reproduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQE Needle, Assisted Reproduction

All 32
Devices cleared under the same product code (MQE) and FDA review panel - the closest regulatory comparables to K031622.
OOCYTE RETRIEVAL NEEDLE SET, MODELS 917-IH AND 917-SH
K051742 · Inntec, Inc. · Oct 2005
MONA LISA ASPIRATION NEEDLE
K032208 · Fertility Technology Resources, Inc. · Dec 2003
EMBRYON ULTRASOUND NEEDLE GUIDE
K032015 · Rocket Medical Plc · Aug 2003
COOPERSURGICAL OOCYTE RECOVERY NEEDLES
K023930 · CooperSurgical, Inc. · Jan 2003
FAS SET #4551
K013497 · Gynetics Medical Products NV · Nov 2001
WALLACE OOCYTE RETRIEVAL SETS 16G, WALLACE OOCYTE RETRIEVAL SET 17G, MODELS MEONS 1633S, MEONS 1733S
K012068 · Sims Portex , Ltd. · Aug 2001
K031622 · WALLACE DUAL LUMEN OOCYTE RETRIEVAL SETS
Download PDF FDA Summary Portex , Ltd.